Login

Financial Snapshot

Revenue
TTM
$2.209K
Gross Margin
TTM
57.2%
Net Income
TTM
-$3.566M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
564.86%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.787M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $10.09 Million

About Caring Brands Inc

Caring Brands Inc (OTC: CABR) is a consumer health and cosmetics company that develops and markets OTC drug products and cosmetic formulations, including the Hair Enzyme Booster (JW-700) and Photocil. The company generates revenue through direct product sales in the U.S. market and through royalty and licensing arrangements with international partners. Caring Brands has a limited operating history, with its S-1 registration filed October 2025 and its 10-K covering fiscal years ended December 31, 2025 and 2024. Products are manufactured by Sanpellegrino Cosmetics Pvt. Ltd. through Stella Indusstries Ltd. under a manufacturing agreement effective May 1, 2024. International distribution rights for India and 31 other territories are licensed to Cosmofix and San Pellegrino Cosmetics, which paid a $20,000 upfront fee and owes minimum annual royalties of $50,000 from the second year. Taisho Pharmaceutical holds an exclusive license to market the Hair Enzyme Booster in Japan, generating royalties for the company on Japanese sales.

Revenue model
Revenue comes from U.S. product sales of OTC and cosmetic products, upfront license fees, and ongoing royalties from international licensing partners. The Cosmofix/San Pellegrino license requires minimum annual royalties of $50,000 from year two onward. The Taisho Pharmaceutical license generates royalties on Japanese sales of the Hair Enzyme Booster.
Products and services
Hair Enzyme Booster (JW-700) and Photocil. The Hair Enzyme Booster is the primary product for U.S. market launch and is also licensed internationally. Both products are classified as OTC drug or cosmetic formulations subject to FDA regulation under FDCA and, where applicable, USP monograph requirements.
Customers and end markets
End markets are consumer health and personal care. No specific customer concentration data is disclosed in the filing excerpts. International distribution targets India and 31 territories including markets in Southeast Asia, the Middle East, and Africa under the Cosmofix/San Pellegrino license. Japan is addressed through the Taisho Pharmaceutical license.
Value-chain role
Brand owner and licensor. Caring Brands owns product formulations and licenses, contracts manufacturing to Sanpellegrino Cosmetics Pvt. Ltd. via Stella Indusstries Ltd., and licenses international rights to regional distributors. The company does not operate its own manufacturing facilities.
Geographic exposure
Primary market is the United States. International licensing covers India and 31 specified territories across South and Southeast Asia, the Middle East, and Africa under the Cosmofix/San Pellegrino License. Japan is covered under the Taisho Pharmaceutical license.

Source: SEC 10-K, filed 2026-03-31

Industry: Perfumes, Cosmetics & Other Toilet Preparations

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support